These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16695841)

  • 1. THE EFFECT OF CUSHING'S SYNDROME UPON SERUM ALBUMIN METABOLISM.
    Sterling K
    J Clin Invest; 1960 Dec; 39(12):1900-8. PubMed ID: 16695841
    [No Abstract]   [Full Text] [Related]  

  • 2. Pitfalls in the diagnosis and management of Cushing's syndrome.
    Bansal V; El Asmar N; Selman WR; Arafah BM
    Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal blood chemistry data in Cushing's syndrome: comparison with those for fatty liver.
    Sato T; Tajiri J; Shimada T; Hiramatsu R; Umeda T
    Endocrinol Jpn; 1984 Dec; 31(6):705-10. PubMed ID: 6532790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and metabolic rhythms in Cushing's syndrome.
    Johnston DG; Alberti KG; Nattrass M; Barnes AJ; Bloom SR; Joplin GF
    Metabolism; 1980 Oct; 29(11):1046-52. PubMed ID: 7001175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome.
    Trainer PJ; Eastment C; Grossman AB; Wheeler MJ; Perry L; Besser GM
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):441-3. PubMed ID: 8287570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic changes in serum steroids for diagnosing and subtyping Cushing's syndrome.
    Ahn CH; Lee C; Shim J; Kong SH; Kim SJ; Kim YH; Lee KE; Shin CS; Kim JH; Choi MH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105856. PubMed ID: 33647522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome.
    Sartorio A; Conti A; Ferrario S; Passini E; Re T; Ambrosi B
    Postgrad Med J; 1996 Jul; 72(849):419-22. PubMed ID: 8935602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some observations on the metabolism of 131-I-albumin in Cushing's syndrome and during adrenocortical hormone administration in man.
    HOFFENBERG R; BLACK EG
    S Afr Med J; 1963 Jan; 37():114-7. PubMed ID: 13963906
    [No Abstract]   [Full Text] [Related]  

  • 10. Leucine metabolism in patients with Cushing's syndrome before and after successful treatment.
    Bowes SB; Benn JJ; Scobie IN; Umpleby AM; Lowy C; Sönksen PH
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):591-8. PubMed ID: 8252750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.
    Kola B; Christ-Crain M; Lolli F; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4969-73. PubMed ID: 18782871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum steroid profiling in Cushing's syndrome patients.
    Hána V; Ježková J; Kosák M; Kršek M; Hána V; Hill M
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105410. PubMed ID: 31201926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midnight salivary cortisol for the diagnosis of Cushing's syndrome in a Chinese population.
    Lin DC; Tsai PS; Lin YC
    Singapore Med J; 2019 Jul; 60(7):359-363. PubMed ID: 30488082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
    Grossman AB; Howlett TA; Perry L; Coy DH; Savage MO; Lavender P; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):167-78. PubMed ID: 2854761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for somatostatin and its analogs in Cushing's syndrome?
    de Herder WW; Lamberts SW
    Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone infusion testing in the diagnosis of Cushing's syndrome.
    Tran HA; Petrovsky N
    Endocr J; 2005 Feb; 52(1):103-9. PubMed ID: 15758565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma.
    Sartorio A; Conti A; Ferrero S; Giambona S; Re T; Passini E; Ambrosi B
    Eur J Endocrinol; 1998 Feb; 138(2):146-52. PubMed ID: 9506857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.